Skip to main content
. 2020 Jan 6;22(5):908–916. doi: 10.1038/s41436-019-0739-z

Fig. 3. D,L-3-Hydroxybutyrate treatment duration.

Fig. 3

Kaplan–Meier plot that demonstrates the cumulative proportion of multiple acyl-CoA dehydrogenase deficiency (MADD)(-like) patients receiving D,L-3-HB treatment over time, categorized according to D,L-3-HB treatment efficacy. Calculated from a total of 23 patients with sufficient data; x = censored patient.